FDA withdraws U.S. authorization for Eli Lilly's COVID drug bebtelovimab

Primary tabs

FDA withdraws U.S. authorization for Eli Lilly's COVID drug bebtelovimab

Fri, 2022-12-02 00:00 — mike kraft

FDA pulls U.S. authorization for Eli Lilly's COVID drug bebtelovimab Eli Lilly and Co's COVID-19 drug bebtelovimab is not currently authorized for emergency use in the United States, the Food and Drug Administration said, citing it is not expected to neutralize the dominant BQ.1 and BQ.1.1 subvariants of Omicron. Reuters Reuters

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Groups this Group Post belongs to:

- Private group -

Log in or register to post comments

Workflow history

Revision ID	Field name	Date	Old state	New state name	By	Comment	Operations
			No state	No state

Resilience System

Main menu

Language

Anonymous's groups in this site

Your groups across all your sites

Recent Content

Recent Comments

Who's online

You are here

FDA withdraws U.S. authorization for Eli Lilly's COVID drug bebtelovimab

Primary tabs

FDA withdraws U.S. authorization for Eli Lilly's COVID drug bebtelovimab

Resilience System

Main menu

User login

Search form

Language

Anonymous's groups in this site

Your groups across all your sites

Recent Content

Recent Comments

Who's online

You are here

FDA withdraws U.S. authorization for Eli Lilly's COVID drug bebtelovimab

Primary tabs

FDA withdraws U.S. authorization for Eli Lilly's COVID drug bebtelovimab